Sanofi-Aventis Canada Inc.

Overview

Sanofi-Aventis Canada Inc. is a subsidiary of the global pharmaceutical company Sanofi. The company is devoted to developing and delivering healthcare solutions for various therapeutic areas, focusing on enhancing patients' quality of life.

Therapeutic areas

API / Drug Master Files

Sanofi-Aventis Canada Inc. holds 1 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MEGLUMINE ANTIMONIATE (GLUCANTIME)Active2021-10-27
• EPLIVANSERIN HEMIFUMARATEInactive2008-07-18
• PYRAZINAMIDEInactive1999-12-16
• MDL 101,731Inactive1995-03-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Sanofi-Aventis Canada Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.